ICD-10-CM Billable Code

D48.6

Neoplasm of uncertain behavior of breast

Clinical Classification Guidelines

Inclusion Terms

  • Neoplasm of uncertain behavior of connective tissue of breast
  • Cystosarcoma phyllodes

Excludes Type 1

  • neoplasm of uncertain behavior of skin of breast (D48.5)

Medical Intelligence & Overview

Neoplasm of uncertain behavior of the breast is a medical diagnosis used when a growth or mass is found in the breast tissue, but it is not clear whether it is benign (non-cancerous) or malignant (cancerous). This category includes conditions like cystosarcoma phyllodes, a rare type of tumor that originates in the connective tissue of the breast and exhibits unpredictable behavior. Due to the uncertain nature of these tumors, careful evaluation and monitoring are essential to determine their true nature and appropriate treatment options.

Causes & Symptoms

Clinical Causes: Unknown factors or genetic predispositions Genetic mutations affecting connective tissue cells Hormonal influences that may stimulate abnormal growth Previous breast injuries or surgeries, though rarely Environmental exposures, though evidence is limited

Key Symptoms: A palpable lump or mass in the breast Breast swelling or enlargements Changes in the shape or size of the breast In some cases, skin changes or nipple discharge, though uncommon Breast tenderness or discomfort

Diagnostic & Treatment

Diagnosis Path: Diagnosing a neoplasm of uncertain behavior involves a combination of medical evaluations, including:

Treatment Protocols: Treatment strategies may vary based on the tumor’s features and behavior, and can include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D48.6 a billable ICD-10 code?
Yes, D48.6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D48.6?
Clinical documentation must specify the nature of Neoplasm of uncertain behavior of breast and any associated comorbidities for accurate reporting.

Cite this Clinical Reference